canagliflozin articles & resources on Made-in-China.com

Mitsubishi Tanabe Pharma Is Seeking Manufacturing and Marketing Approval of TA-7284

May 27, 2013

Mitsubishi Tanabe Pharma is seeking manufacturing and marketing approval of TA-7284 (generic name: canagliflozin) in Japan. The company filed a new drug application to the Ministry of Health, Labor and Welfare in Japan for TA-7284 to ...

Tags: Mitsubishi, canagliflozin

FDA Has Approved Janssen's Invokana for The Treatment of Adults

Apr 2, 2013

The US food and drug administration (FDA) has approved Janssen's Invokana (canagliflozin) for the treatment of adults with type 2 diabetes. Invokana is the oral, once-daily medication available in the US demonstrating improved glycemic ...

Tags: Health, Medicine

Janssen Has Submitted a New Drug Application to The Us FDA for a Fixed-Dose Therapy

Dec 14, 2012

Janssen Research & Development has submitted a New Drug Application (NDA) to the US FDA seeking approval for a fixed-dose therapy combining canagliflozin and immediate release metformin to treat patients with type 2 diabetes. ...

Tags: Janssen, NDA, FDA, therapy

The Filing Is Based on a Global Phase III Clinical Development Program

Dec 4, 2012

Janssen Research & Development has submitted a new drug application (NDA) to the FDA for canagliflozin to treat adult patients with type 2 diabetes. The filing is based on a global Phase III clinical development program, including nine ...

Tags: Janssen Research&Development, SGLT2, cardiovascular study

canagliflozin

Mitsubishi Tanabe Pharma Is Seeking Manufacturing and Marketing Approval of TA-7284

FDA Has Approved Janssen's Invokana for The Treatment of Adults

Janssen Has Submitted a New Drug Application to The Us FDA for a Fixed-Dose Therapy

The Filing Is Based on a Global Phase III Clinical Development Program

Related Products